AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $165.43
- 52-wk low
- $117.98
- Prev close
- $144.33
- Mkt cap
- $293.76B
- P/E
- 22.9x
- Fwd P/E
- 17.0x
Smart money
Earnings
Earnings came in 9.5% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $14.36B | $13.33B | $13.52B | $14.42B |
| Cost of what it sold | $3.54B | $3.54B | $3.46B | $3.68B |
| Gross profit | $10.82B | $9.79B | $10.06B | $10.74B |
| What it spent | ||||
| Research and development | $2.94B | $2.84B | $2.74B | $2.76B |
| Sales and admin | $3.31B | $3.44B | $3.14B | $3.24B |
| Other operating costs | $66.0M | — | — | — |
| Total operating expenses | $6.32B | $6.27B | $5.83B | $6.00B |
| What was left | ||||
| Operating profit | $4.50B | $3.52B | $4.24B | $4.74B |
| Interest on debt | $281.0M | $304.0M | $343.0M | $462.3M |
| Profit before tax | $4.20B | $3.22B | $3.84B | $4.27B |
| Tax | $266.0M | $813.9M | $683.0M | $1.01B |
| Net profit | $3.93B | $2.41B | $3.16B | $3.27B |
| EBITDA | $5.84B | $5.07B | $5.41B | $5.94B |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
20 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Trust Co. of Vermont Purchases New Position in Novartis AG $NVS
NeutralAug 18Novartis AG (NYSE:NVS) Receives Average Recommendation of "Hold" from Brokerages
NeutralAug 18Novartis stock holds firm after Q4 earnings beat and steady outlook
BullishAug 18
